English version not available. Please check the Spanish version.
Valentina Melo-Pedroza 1 , Manuela Jaramillo-Sierra 2
, Gabriela Prieto-Angarita 3
, Andrea Ascencio-Medina 4
, Catalina Solano 5
1 Departamento de Urología, Fundación Santafé de Bogotá, Bogotá, Colombia; 2 Departamento de psiquiatría, Fundación Santafé de Bogota, Bogotá D.C., Colombia; 3 Departamento de Urgencias, Hospital Universitario de Santander, Bucaramanga, Colombia; 4 Ayudantía quirúrgica, Clínica del Country, Bogotá, Colombia; 5 Departamento de Endourología, Uroclin S.A.S, Medellín, Colombia
*Correspondence: Catalina Solano. Email: catasolano84@gmail.com
Objective: ChatGPT is an AI (artificial intelligence) pre-trained based in GPT-3.5 architecture, which was launched in November 2022. This AI simulates an every-day chat, responding to different sorts of topics and its widely used in scientific production. Our objective is to identify and analyze the publication trends about ChatGPT and its uses in medicine around the world.
Method: Published article since ChatGPT launch (2022) until April 2023 were included. Medline and Embase data bases were used to run the search. We evaluated the impact factor (IF) 2021, the Journal Citation Reports (JCR) using Clarivate Analytics and H index using SCImago. We also used map analysis through VOSViewer and graphed the data.
Results: The search gathered 533 articles which were reduced and picked 309 of them. Cureus journal and medRxiv lead the most publications top ten. Only three of the urology-related journals have publications regarding ChatGPT. USA, England and Netherlands are the countries with most scientific productions and the most frequent type of article were original articles (22.7%).
Conclusion: ChatGPT may be the beginning of a new worldwide era which will ease-up several processes in healthcare. Different medical sciences are investigating around this tool looking for opportunities and disadvantages. It is fundamental to know the uses and limitations with this type of chatbot for applying it in healthcare without trespassing ethical boundaries.
Keywords:
English version not available. Please check the Spanish version.
Text only available in Spanish.
Mallorca, 310
08037 Barcelona (España)
Arquímedes, 190 – Colonia Polanco
Delegación Miguel Hidalgo
11560 Ciudad de México (México)
This journal adheres to the principles established by the Committee on Publication Ethics
The editorial process consists of 6 stages:
1. Reception of the manuscript (indeterminate, depending on whether the author meets the requirements): its objective is to verify that the manuscript complies with the specifications of these instructions for authors and that the submitted documentation is complete.
2. Initial editorial review (maximum 5 business days): its objective is to corroborate the relevance, timeliness, originality, and scientific contribution of the manuscript, as well as the methodological and statistical soundness of the study. At this time, it will be submitted to an electronic plagiarism detection system. Derived from this, a rejected opinion may be obtained, or it will be sent for review by peer researchers.
3. Review by peer researchers (maximum 30 business days): the opinion of at least two experts in the area in question will be obtained, who will evaluate the technical and methodological aspects of the investigation.
4. Editorial review (maximum 7 business days): its objective is to make a decision based on the opinion of peer reviewers. The opinion can be rejected, major changes, minor changes or accepted. In the case of major or minor changes, it will be submitted again for evaluation by the initial peer reviewers.
5. Final edition (6 weeks): its objective is the technical and linguistic edition (and translation), layout of galleys, DOI assignment, and correction by the author.
6. Advanced publication: All manuscripts will be published ahead of print on the journal’s website as soon as they complete the editing process, until they are incorporated into a final issue of the journal.